- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
A Pink Eye
A 43-year-old man had left eye irritation for 2 weeks. He denied trauma, headache, eye discharge, fever, cough, or vomiting; he had mild photophobia and slightly blurred vision. Your Dx?
A 43-year-old man had left eye irritation for 2 weeks. He denied trauma, headache, eye discharge, fever, cough, or vomiting; he had mild photophobia and slightly blurred vision. There was mild bilateral photophobia and consensual photophobia. No swelling, temporal artery tenderness, proptosis, or eye pain with motion.
Your Dx?
Sotagliflozin in Patients with Type 1 Diabetes and CKD to be Discussed at October FDA AdComm Meeting
October 14th 2024Lexicon's sotagliflozin is on the October 31 docket for discussion by the FDA's Endocrinologic and Metabolic Drugs Advisory Committee; PDUFA goal date remains set for December 20.
